Rigenerand Srl
Medolla
About Rigenerand Srl
RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.Founded in 2009 by Prof. Massimo Dominici and Prof. Pierfranco Conte, as a spin-off resulting from a joint venture between biomedical company RanD and researchers from the University of Modena and Reggio Emilia, Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative biocompatible materials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $9.9M
- Funding stage: M&A
- Last round: Series Unknown (May 2016)
- Website: rigenerand-biotech.com
- Phone: +39053549307
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/rigenerand-srl-183202 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.